General Information of Drug Off-Target (DOT) (ID: OTJDWX99)

DOT Name Enhancer of rudimentary homolog (ERH)
Gene Name ERH
Related Disease
Neoplasm ( )
Hepatocellular carcinoma ( )
Bladder cancer ( )
Bladder transitional cell carcinoma ( )
Urinary bladder cancer ( )
Urinary bladder neoplasm ( )
UniProt ID
ERH_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1W9G; 2NML; 7CNC; 7X39
Pfam ID
PF01133
Sequence
MSHTILLVQPTKRPEGRTYADYESVNECMEGVCKMYEEHLKRMNPNSPSITYDISQLFDF
IDDLADLSCLVYRADTQTYQPYNKDWIKEKIYVLLRRQAQQAGK
Function May have a role in the cell cycle.
Tissue Specificity Expressed in all tissues examined.

Molecular Interaction Atlas (MIA) of This DOT

6 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Neoplasm DISZKGEW Definitive Altered Expression [1]
Hepatocellular carcinoma DIS0J828 Strong Biomarker [2]
Bladder cancer DISUHNM0 Limited Biomarker [3]
Bladder transitional cell carcinoma DISNL46A Limited Biomarker [3]
Urinary bladder cancer DISDV4T7 Limited Biomarker [3]
Urinary bladder neoplasm DIS7HACE Limited Biomarker [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
11 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Enhancer of rudimentary homolog (ERH). [4]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Enhancer of rudimentary homolog (ERH). [5]
Arsenic trioxide DM61TA4 Approved Arsenic trioxide decreases the expression of Enhancer of rudimentary homolog (ERH). [7]
Methotrexate DM2TEOL Approved Methotrexate decreases the expression of Enhancer of rudimentary homolog (ERH). [8]
Marinol DM70IK5 Approved Marinol increases the expression of Enhancer of rudimentary homolog (ERH). [9]
Cannabidiol DM0659E Approved Cannabidiol increases the expression of Enhancer of rudimentary homolog (ERH). [10]
Clozapine DMFC71L Approved Clozapine increases the expression of Enhancer of rudimentary homolog (ERH). [10]
Benzatropine DMF7EXL Approved Benzatropine increases the expression of Enhancer of rudimentary homolog (ERH). [10]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Enhancer of rudimentary homolog (ERH). [11]
chloropicrin DMSGBQA Investigative chloropicrin decreases the expression of Enhancer of rudimentary homolog (ERH). [12]
AHPN DM8G6O4 Investigative AHPN decreases the expression of Enhancer of rudimentary homolog (ERH). [13]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Arsenic increases the ubiquitination of Enhancer of rudimentary homolog (ERH). [6]
------------------------------------------------------------------------------------

References

1 Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells.Proc Natl Acad Sci U S A. 2012 Dec 26;109(52):E3659-67. doi: 10.1073/pnas.1207673110. Epub 2012 Dec 10.
2 Enhancer of rudimentary homolog regulates DNA damage response in hepatocellular carcinoma.Sci Rep. 2015 Apr 9;5:9357. doi: 10.1038/srep09357.
3 The ERH gene regulates migration and invasion in 5637 and T24 bladder cancer cells.BMC Cancer. 2019 Mar 12;19(1):225. doi: 10.1186/s12885-019-5423-9.
4 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
5 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
6 Quantitative Assessment of Arsenite-Induced Perturbation of Ubiquitinated Proteome. Chem Res Toxicol. 2022 Sep 19;35(9):1589-1597. doi: 10.1021/acs.chemrestox.2c00197. Epub 2022 Aug 22.
7 Proteomics-based identification of differentially abundant proteins from human keratinocytes exposed to arsenic trioxide. J Proteomics Bioinform. 2014 Jul;7(7):166-178.
8 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
9 Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells. Anticancer Res. 2015 Nov;35(11):5827-37.
10 Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.
11 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
12 Transcriptomic analysis of human primary bronchial epithelial cells after chloropicrin treatment. Chem Res Toxicol. 2015 Oct 19;28(10):1926-35.
13 ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis. Blood. 2004 Jan 1;103(1):194-207.